Skip to main content
High RiskFDAfda-F-1091-2016LISTERIA

Seasons Choice Prince Edward Medley Net Wt. 16 oz. Distributed by: Aldi Inc. Batavia, IL 60510 Product of Netherlands UPC will b...

Category
Units Affected
47,562
Recall Date
March 1, 2016
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1091-2016.

The recall is being issued as a precaution after a limited number of product tested positive for the presence of Listeria monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1091-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Camericam International Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1091-2016.

Camericam International Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Camericam International Inc Recall FAQ

Camericam International Inc is the subject of a food safety report: Seasons Choice Prince Edward Medley Net Wt. 16 oz. Distributed by: Aldi Inc. Batavia, IL 60510 Product of Netherlands UPC will b.... The notice was published on March 1, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 47,562 units are potentially affected.